FDA — authorised 28 February 2022
- Application: NDA208712
- Marketing authorisation holder: SOBI
- Local brand name: VONJO
- Indication: CAPSULE — ORAL
- Status: approved
🇺🇸 Vonjo in United States
FDA authorised Vonjo on 28 February 2022
Marketing authorisations
FDA — authorised 18 March 2022
- Marketing authorisation holder: MARINUS PHARMA INC
- Status: approved
Vonjo in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in United States
Frequently asked questions
Is Vonjo approved in United States?
Yes. FDA authorised it on 28 February 2022; FDA authorised it on 18 March 2022.
Who is the marketing authorisation holder for Vonjo in United States?
SOBI holds the US marketing authorisation.